Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
0.330
+0.009 (2.71%)
Apr 25, 2024, 12:06 PM EDT - Market open

Telesis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
101235317--
Market Cap Growth
--66.23%-88.81%---
Enterprise Value
242713251-5-24
PE Ratio
-0.24-0.24-0.73-8.12--
PS Ratio
0.340.441.2928.66--
PB Ratio
39.4850.270.763.49--
P/FCF Ratio
-0.33-0.33-0.82-8.21--
P/OCF Ratio
-0.35-0.35-0.92-8.62--
EV/Sales Ratio
0.890.980.4822.73-0.78-5.07
EV/EBITDA Ratio
-0.67-0.67-0.30-6.970.324.09
EV/EBIT Ratio
-0.61-0.61-0.28-6.680.303.58
EV/FCF Ratio
-0.74-0.74-0.30-6.510.333.77
Debt / Equity Ratio
144.45144.450.460.19-0.33-0.64
Debt / EBITDA Ratio
-0.85-0.85-0.49-0.48-0.53-0.80
Debt / FCF Ratio
-0.94-0.94-0.50-0.45-0.53-0.74
Quick Ratio
3.093.093.678.882.8017.79
Current Ratio
3.713.714.089.573.0518.25
Asset Turnover
0.290.290.290.110.20-
Interest Coverage
-14.36-14.36-23.78-27.45-25.09-4.57
Return on Equity (ROE)
-237.60%-237.60%-79.90%-57.00%109.30%-
Return on Assets (ROA)
-51.70%-51.70%-51.30%-38.10%-54.90%-
Return on Capital (ROIC)
-134.44%-134.44%-68.37%-32.78%95.93%255.06%
Earnings Yield
-521.80%-409.78%-136.82%-12.31%--
FCF Yield
-389.89%-306.19%-121.90%-12.18%--
Buyback Yield / Dilution
-1.31%-1.31%-61.69%-264.34%66.66%-
Total Shareholder Return
-1.31%-1.31%-61.69%-264.34%66.66%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).